Kernal Biologics
PrivateLast Round
Grant
Oct 7, 2025
Total Funding Raised
$25M
Company Overview
Kernal Biologics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in July 2022.
Kernal Biologics is a biotechnology company that develops mRNA-based immunotherapies for cancer and autoimmune diseases using AI-designed, cell-selective mRNA and targeted lipid nanoparticle technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, NLP & Conversational AI, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kernal Biologics Comparables
Compare Kernal Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HelixNano | 86% | |
| Chimeron Bio | 86% | |
| Strand Therapeutics | 83% |
For institutional investors. Book with your work email.
Kernal Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2025 | ||||
| Series A | Jul 7, 2022 |
For institutional investors. Book with your work email.
Kernal Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amino Collective | Series A |
| HBM Healthcare Investments | Series A |
| Amgen Ventures | Series A |
| ARPA-H | Grant |
| Civilization Ventures | Series A |
| Hummingbird Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Grew 19% QoQ, from 16 to 19 employees.
- Oct 8, 2025
KR-402 is in development for B cell cancers.
For institutional investors. Book with your work email.
Kernal Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kernal Biologics's valuation, stock price, and market status.
Is Kernal Biologics a public or private company?
Kernal Biologics is a private company.
What is the current stock price of Kernal Biologics?
Kernal Biologics is a private company, so its shares have no public market price. Caplight tracks Kernal Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kernal Biologics worth (valuation)?
Valuation information for Kernal Biologics is not publicly available.
Can I buy Kernal Biologics stock?
Kernal Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kernal Biologics's last funding round?
Kernal Biologics's most recent funding round was Grant on October 7, 2025.
Who are the main investors in Kernal Biologics?
Key investors in Kernal Biologics include Hummingbird Ventures.
Will Kernal Biologics IPO soon?
No public IPO plans have been announced for Kernal Biologics.
How can I track Kernal Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Kernal Biologics's shares on secondary markets.